Biosortia Microbiomics
Dr. Carter has over 30 years of experience working in Pharmaceutical R&D, primarily in the discovery and development of microbial products. In the course of his career in the pharmaceutical industry, he worked as a natural products discovery scientist and advanced through levels of scientific management to gain the overall leadership of the Natural Products Discovery function at Wyeth Research (later acquired by Pfizer), as well as directing other elements of the Chemical Technologies Department. Guy received a doctorate in Biochemistry from the University of Wisconsin-Madison, and then pursued marine natural products research on an NIH-sponsored post-doctoral fellowship with Kenneth Rinehart at the University of Illinois.
This person is not in any offices
Biosortia Microbiomics
Biosortia is modernizing and vastly improving what historically is the most successful approach to drug discovery - a methodology that previously accessed less than 1% we can now effectively open the other 99% to exploration.